4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ: FDMT · IEX Real-Time Price · USD

14.40

-0.74 (-4.89%)

At close: Jul 19, 2024, 4:00 PM

14.55

+0.15 (1.04%)

Pre-market: Jul 22, 2024, 7:29 AM EDT

4D Molecular Therapeutics Market Cap

4D Molecular Therapeutics has a market cap or net worth of $744.53 million as of July 22, 2024. Its market cap has increased by 23.74% in one year.

Market Cap

744.53M

Enterprise Value

232.79M

1-Year Change

23.74%

Ranking

#2692

Market Cap Chart

Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has increased from $580.38M to $744.53M, an increase of 28.28%. That is a compound annual growth rate of 7.15%.

Market Cap History

Date	Market Cap	% Change
Jul 19, 2024	744.50M	-14.05%
Dec 29, 2023	866.20M	20.41%
Dec 30, 2022	719.40M	2.03%
Dec 31, 2021	705.10M	-28.63%
Dec 31, 2020	987.90M	70.22%

View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Embecta	759.52M
Phibro Animal Health	754.99M
Evolus	748.82M
Travere Therapeutics	746.06M
Pliant Therapeutics	745.63M
Nuvation Bio	743.01M
Sage Therapeutics	739.64M
Savara	735.03M

Market Cap Rankings